Sort
39,280 grants matching “leukemia”
Oncogenic tyrosine kinases inhibitors abrogate DNA repair and sensitive leukemias to PARP inhibitors
$376,152Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2020 · CA
c-Abl and PKC-eta in Cell Development and Leukemia
$376,137University Of California Berkeley · R01 · FY2005 · AI
Generating an atlas of Richter's Syndrome: from molecular understanding to outcome prediction, detection and monitoring
$376,109Gad A Getz · Dana-Farber Cancer Inst · P01 · FY2023 · CA
Project 1: Targeting the MYC Pathway in Prostate Cancer
$376,100Sarki A. Abdulkadir · Northwestern University At Chicago · P50 · FY2022 · CA
Project 1: Targeting the MYC Pathway in Prostate Cancer
$376,099Sarki A. Abdulkadir · Northwestern University At Chicago · P50 · FY2023 · CA
Function and targeting of a stable transcription factor complex in leukemia
$376,098Robert G Roeder · Rockefeller University · R01 · FY2019 · CA
Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML
$376,095Terzah M Horton · Baylor College Of Medicine · R01 · FY2015 · CA
E2A AS A POTENTIAL TUMOR SUPPRESSOR
$376,014University Of California San Diego · R01 · FY2001 · CA
SUMO-dependent Regulation of Ubiquitin Ligases in Genomic Stability
$376,002Michael Nicholas Boddy · Scripps Research Institute, The · R01 · FY2010 · GM
Project 1: Evaluation of UAB30 on skin cancer biomarkers in human renal transplant recipients
$375,966Craig A Elmets · University Of Alabama At Birmingham · P01 · FY2020 · CA
Regulation of Hematopoietic Progenitors by de novo DNA Methylation
$375,963Margaret Goodell · Baylor College Of Medicine · R01 · FY2013 · DK
Therapeutic targeting of RNA splicing catalysis through inhibition of Protein Arginine Methylation
$375,903Ernesto Guccione · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Molecular understanding of leukemic bone marrow cytokine-Ras signals and metabolic dependence
$375,891Jeroen Roose · University Of California, San Francisco · R01 · FY2023 · CA
New activities of the human DEK oncogene
$375,871Susanne Irmtraud Wells · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · CA
T(8;21) in Blood Cell Proliferation and Differentiation
$375,869Scripps Research Institute · R01 · FY2005 · CA
T(8;21) in Blood Cell Proliferation and Differentiation
$375,869Scripps Research Institute · R01 · FY2004 · CA
T(8;21) in Blood Cell Proliferation and Differentiation
$375,869Scripps Research Institute · R01 · FY2003 · CA
Advanced development and validation of targeted molecular counting methods for precise and ultrasensitive quantitation of low prevalence somatic mutations
$375,858Stephen J Salipante · University Of Washington · R33 · FY2015 · CA
Advanced development and validation of targeted molecular counting methods for precise and ultrasensitive quantitation of low prevalence somatic mutations
$375,858Stephen J Salipante · University Of Washington · R33 · FY2016 · CA
Advanced development and validation of targeted molecular counting methods for precise and ultrasensitive quantitation of low prevalence somatic mutations
$375,858Stephen J Salipante · University Of Washington · R33 · FY2017 · CA
Multi-Scale Cancer Modeling: From Cell Phenotypes to Cancer Spread and Response
$375,857Vittorio Cristini · University Of Southern California · U54 · FY2010 · CA
Dartmouth Lead Participation in NCI National Clinical Trials Network
$375,850Konstantin H. Dragnev · Dartmouth College · U10 · FY2016 · CA
Dartmouth Lead Participation in NCI National Clinical Trials Network
$375,850Konstantin H. Dragnev · Dartmouth College · U10 · FY2014 · CA
DEVELOPMENT & EVALUATION OF PRACTICABLE APPROACHES FOR GENERATION OF CYTOTOXIC &
$375,823Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2008 · CA
Roles of Endogenous Retroviruses in Cancer and Auto-immune Diseases
$375,784Leonard Evans · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI